Patents
Literature
Patsnap Copilot is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Patsnap Copilot

301results about How to "Relieve inflammation" patented technology

Medicament for treating acquired immune deficiency syndrome (AIDS)

The invention provides a completely oral medicament for treating acquired immune deficiency syndrome (AIDS), comprising the following components: hedyotis diffusa, honeysuckle, meadowrueleaf corydalis root, dandelion, weeping forsythia, asparagus, ophiopogon root, figwort root, fresh rehmannia root, peach kernel, chuanxiong rhizome, zedoary, achyranthes root, dahurian patrinia herb, giant knotweed, stiff silkworm, isatis root, white peony root, polygonatum, bitter caramon, mistletoe, tortoise plastron, glossy privet fruit, oyster, pollen, salvia miltiorrhiza, tree peony bark, bupleurum, bitter orange, cimicifuga foetida, dried orange peel, amomum fruit, officinal magnolia bark, rose, songaria cynomorium herb, self-heal, medicine terminalia fruit, gromwell, licorice, chrysanthemum, castor bean, bullfrog gallbladder, baikal skullcap root, medicated leaven, malt, rice sprout, chicken's gizzard-skin, radish seed, scorch-fried crataegus, Chinese yam, astragalus root, bighead atractylodes rhizome, sealwort, dangshen, prepared rehmannia root, cornus fruit, tuckahoe, jujube, Chinese wolfberry, cistanche, dragon bone, oyster, epimedium, curculigo root, deerhorn glue, ginseng, donkey-hide glue, white fungus, angelica, spatholobus stem and turtle shell. The medicament provided by the invention not only can cure AIDS and has good therapeutic effect on AIDS, but also can prevent infection of AIDS.
Owner:肖嘉惠

Nano-emulsion with good stability

The invention discloses a nano-emulsion with good stability. A formula of the nano-emulsion is prepared from the following components in percentage by weight: 30.0-82.13 percent of purified water, 0.01-0.1 percent of EDTA disodium, 0.5-5.0 percent of hydrogenated lecithin, 0.3-5.0 percent of a nonionic surfactant, 0.5-5.0 percent of caprylic acid/caprinic acid triglyceride, 5.0-30 percent of squalane, 1.0-5.0 percent of isononyl isononanoate, 0.01-0.5 percent of tocopheryl acetate, 0.5-3.0 percent of 1,2-hexanediol, 10.0-40.0 percent of glycerin and 0.05-8.0 percent of an oil-soluble skin conditioner. Through reasonable selection and ratio blending of components of the nano-emulsion, the strength and the elasticity of an interfacial film are improved, the interface energy is lowered, the mobility of the interfacial film is reduced, and the nano-emulsion with the stability to temperature change is prepared. The nano-emulsion wraps various efficient skin-care components and promotes transdermal absorption of functional components; and in addition, the hydrogenated lecithin as an emulsifier has better physiological activity, promotes substance metabolism of epidermic cells and enablesskin to be more pliable, tougher and more elastic; and modified soyasterol has the effect of relieving skin inflammation.
Owner:NOX BELLCOW COSMETICS CO LTD

Use of modified polysaccharide rich in mannose in preparing medicine for preventing the colitis cancer

The invention relates to the application of a mannose-enriched polysaccharide to drug preparation, in particular to the application of a mannose-enriched modified polysaccharide to the preparation of drugs for preventing colonitis from cancerization. Aiming to make up the blank of the drugs for preventing the inflammatory bowel diseases and especially the ulcerative colitis from cancerization, the application provides the technical proposal that the mannose-enriched modified polysaccharide is applied to the drugs for preventing the colonitis from cancerization, and the modified polysaccharide contains a modified natural gum or a modified plant polysaccharide. The application has the characteristics that a mannose receptor (MR) is taken as a target; the mannose-enriched polysaccharide is separated and extracted from a medicinal plant, and mannosidase is adopted for hydrolyzation; mannose residues are exposed, and regulate gut immunity and relieve the intestinal inflammation after being combined with the MR on the surface of immunological cells, thereby preventing the inflammatory bowel diseases and especially the ulcerative colitis from cancerization. After the mannose-enriched modified polysaccharide is used on a big mouse suffering from the ulcerative colitis, the cancerization inhibitory rate of the ulcerative colitis can reach 93 percent.
Owner:FOURTH MILITARY MEDICAL UNIVERSITY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products